Bruno M. Costa

3.0k total citations
72 papers, 2.2k citations indexed

About

Bruno M. Costa is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Bruno M. Costa has authored 72 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 23 papers in Genetics and 22 papers in Cancer Research. Recurrent topics in Bruno M. Costa's work include Glioma Diagnosis and Treatment (20 papers), Epigenetics and DNA Methylation (12 papers) and MicroRNA in disease regulation (11 papers). Bruno M. Costa is often cited by papers focused on Glioma Diagnosis and Treatment (20 papers), Epigenetics and DNA Methylation (12 papers) and MicroRNA in disease regulation (11 papers). Bruno M. Costa collaborates with scholars based in Portugal, Brazil and United States. Bruno M. Costa's co-authors include Céline S. Gonçalves, Rui Manuel Reis, Ana Xavier‐Magalhães, J Costello, Joana Vieira de Castro, Jun S. Song, Robert J.A. Bell, Andrew Mancini, Cármen Jerónimo and Rui Henrique and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Cell.

In The Last Decade

Bruno M. Costa

67 papers receiving 2.2k citations

Peers

Bruno M. Costa

GENET

ONCOL

PRM

Shiming He China

Susanne Adams Germany

Takashi Sasayama Japan

Annette Meeson United Kingdom

Kevin Pumiglia United States

Chuanlu Jiang China

Kerrie L. McDonald Australia

Marsha J. Merrill United States

Hao Xue China

Sameer Agnihotri Canada

Shiming He China

Bruno M. Costa

1.6k ×1.3

851 ×1.1

201 ×0.4

GENET

435 ×1.2

ONCOL

385 ×1.4

PRM

Citations per year, relative to Bruno M. Costa Bruno M. Costa (= 1×) peers Shiming He

Countries citing papers authored by Bruno M. Costa

Since Specialization

Citations

This map shows the geographic impact of Bruno M. Costa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno M. Costa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno M. Costa more than expected).

Fields of papers citing papers by Bruno M. Costa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruno M. Costa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno M. Costa. The network helps show where Bruno M. Costa may publish in the future.

Co-authorship network of co-authors of Bruno M. Costa

This figure shows the co-authorship network connecting the top 25 collaborators of Bruno M. Costa. A scholar is included among the top collaborators of Bruno M. Costa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruno M. Costa. Bruno M. Costa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Castro, Joana Vieira de, et al.. (2024). Relevance of HOTAIR rs920778 and rs12826786 Genetic Variants in Bladder Cancer Risk and Survival. Cancers. 16(2). 434–434. 2 indexed citations

Oliveira, Andressa Feitosa Bezerra de, et al.. (2024). Beyond Fluoride: Exploring Silicon’s Potential for Dental Repair and Caries Prevention. SHILAP Revista de lepidopterología. 4(4). 578–588.

Gonçalves, Céline S., et al.. (2024). Emerging roles and biomarker potential of WNT6 in human cancers. Cell Communication and Signaling. 22(1). 538–538. 2 indexed citations

Miranda‐Gonçalves, Vera, João Lobo, Vera Constâncio, et al.. (2022). Cadherin switches during epithelial-mesenchymal transition: CDH4/RCAD downregulation reduces bladder cancer progression. Cellular Oncology. 45(1). 135–149. 3 indexed citations

Oliveira, Ana I., Heleen H. Van Acker, Ewout Landeloos, et al.. (2021). Plexin-A4 Mediates Cytotoxic T-cell Trafficking and Exclusion in Cancer. Cancer Immunology Research. 10(1). 126–141. 11 indexed citations

Castro, Joana Vieira de, Céline S. Gonçalves, Irene Miranda‐Lorenzo, et al.. (2021). Intracellular Autofluorescence as a New Biomarker for Cancer Stem Cells in Glioblastoma. Cancers. 13(4). 828–828. 5 indexed citations

Gonçalves, Céline S., Marta Pojo, Rita Carvalho, et al.. (2021). Cadherin‐3 is a novel oncogenic biomarker with prognostic value in glioblastoma. Molecular Oncology. 16(14). 2611–2631. 9 indexed citations

Miranda‐Gonçalves, Vera, Céline S. Gonçalves, Sara Granja, et al.. (2021). MCT1 Is a New Prognostic Biomarker and Its Therapeutic Inhibition Boosts Response to Temozolomide in Human Glioblastoma. Cancers. 13(14). 3468–3468. 28 indexed citations

Martins, Renato, Bruno M. Costa, Cláudia Carvalho, et al.. (2020). Prognostic Factors After Hepatectomy for Gastric Adenocarcinoma Liver Metastases: Desmoplastic Growth Pattern as the Key to Improved Overall Survival. SHILAP Revista de lepidopterología.

10.

Monteiro‐Reis, Sara, Ana Lameirinhas, Vera Miranda‐Gonçalves, et al.. (2020). Sirtuins’ Deregulation in Bladder Cancer: SIRT7 Is Implicated in Tumor Progression through Epithelial to Mesenchymal Transition Promotion. Cancers. 12(5). 1066–1066. 23 indexed citations

11.

Gonçalves, Céline S., Ana Xavier‐Magalhães, Manuel Melo Pires, et al.. (2020). A novel molecular link between HOXA9 and WNT6 in glioblastoma identifies a subgroup of patients with particular poor prognosis. Molecular Oncology. 14(6). 1224–1241. 28 indexed citations

12.

Gonçalves, Céline S., et al.. (2020). HOX gene cluster (de)regulation in brain: from neurodevelopment to malignant glial tumours. Cellular and Molecular Life Sciences. 77(19). 3797–3821. 41 indexed citations

13.

Castro, Joana Vieira de, Céline S. Gonçalves, Adı́lia Hormigo, & Bruno M. Costa. (2020). Exploiting the Complexities of Glioblastoma Stem Cells: Insights for Cancer Initiation and Therapeutic Targeting. International Journal of Molecular Sciences. 21(15). 5278–5278. 29 indexed citations

14.

Barros‐Silva, Daniela, Elena Aznar, Jorge Oliveira, et al.. (2020). MicroRNA-30a-5pme: a novel diagnostic and prognostic biomarker for clear cell renal cell carcinoma in tissue and urine samples. Journal of Experimental & Clinical Cancer Research. 39(1). 98–98. 46 indexed citations

15.

Oliveira, Ana I., Sandra I. Anjo, Joana Vieira de Castro, et al.. (2017). Crosstalk between glial and glioblastoma cells triggers the “go-or-grow” phenotype of tumor cells. Cell Communication and Signaling. 15(1). 37–37. 40 indexed citations

16.

Luís, Ana, Pedro Costa‐Pinheiro, Luís Antunes, et al.. (2017). SETDB2 and RIOX2 are differentially expressed among renal cell tumor subtypes, associating with prognosis and metastization. Epigenetics. 12(12). 1057–1064. 14 indexed citations

17.

Miranda‐Gonçalves, Vera, Sara Granja, Olga Martinho, et al.. (2016). Hypoxia-mediated upregulation of MCT1 expression supports the glycolytic phenotype of glioblastomas. Oncotarget. 7(29). 46335–46353. 90 indexed citations

18.

Mello, Ramon Andrade de, Bruno M. Costa, Rui Manuel Reis, & Venceslau Hespanhol. (2011). Insights into Angiogenesis in Non-Small Cell Lung Cancer: Molecular Mechanisms, Polymorphic Genes, and Targeted Therapies. Recent Patents on Anti-Cancer Drug Discovery. 7(1). 118–131. 24 indexed citations

19.

Costa, Bruno M., Justin S. Smith, Ying Chen, et al.. (2010). Reversing HOXA9 Oncogene Activation by PI3K Inhibition: Epigenetic Mechanism and Prognostic Significance in Human Glioblastoma. Cancer Research. 70(2). 453–462. 122 indexed citations

20.

Costa, Bruno M., Luís M. S. Dias, José A. Oliveira, & Guilherme Pereira. (2008). Simulation as a tool for planning a material delivery system to manufacturing lines. 1–5. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact